Dolphimed A/S: Financial statements 2024
CVR: 42539023
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Dolphimed A/S (CVR 42539023) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -163,373 and a net result of DKK -5,168,947 compared with DKK -6,435,051 the year before. Equity in the 2024 report amounted to DKK -31,334,659. The company had 1 employee in the financial year.
- Gross Profit
- DKK -163,373
- Profit/Loss
- DKK -5,168,947
- Equity
- DKK -31,334,659
- Total Assets
- DKK 16,105,714
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -163 t. | -5.2 mio. | -31.3 mio. | 1 |
| 2023 | - | -1.9 mio. | -6.4 mio. | -26.2 mio. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Dolphimed A/S has published its annual report for 2023. Gross profit came to DKK -1,931,937, and the net result was DKK -6,435,051.
About Dolphimed A/S
Dolphimed A/S is a Danish company of the type Aktieselskab based in København K, founded in 2021. The company is in liquidation. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named A/S KBUS 18 nr. 198. The management consists of Preben Jakobsen. The company is owned by Asset Segregated SPV #114 IC, Escala Capital AS and KOMM-IN AS. The company has 1 employee (2022). In 2024, the company reported a gross profit of DKK -163,373 and a net result of DKK -5,168,947 compared with DKK -6,435,051 the year before. Equity in the 2024 report amounted to DKK -31,334,659.